Home »
Academic Articles & Research Papers
Showing 20 of 48 academic articles
Xin Zhang, Ruonan Lian, Bingbing Fan, Lei Meng et al. • Pharmaceutics
(2025)
Objectives: Colorectal cancer (CRC) is a leading cause of cancer-related mortality, driven by chronic inflammation, gut microbiota dysbiosis, and complex tumor microenvironment interactions. Current therapies are limited by systemic toxicit...
DOAJ
Open Access (DOAJ)
DOI: 10.3390/pharmaceutics17070940
Simone Meira Carvalho, Camilla de Abrahão Andrade, Mariana Barbosa Leite Sérgio Ferreira, Karine Soriana Silva de Souza et al. • PLoS ONE
(2023)
Background Breast cancer is considered a health problem at a worldwide level. In Brazil, the South and Southeast regions have the highest mortality rates. Understanding how they dealt with the diagnostic of a stigmatized disease amid the CO...
DOAJ
Open Access (DOAJ)
Zhang H, Liang Y, Li C, Wu B et al. • Frontiers in medicine
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.3389/fmed.2026.1994701
PMC: PMC13728853
Van Truong N, Nguyen T-K, Sy Thau N, Chu T-TH et al. • Antimicrobial agents and chemotherapy
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1128/aac.00382-26
PMC: PMC13731232
Song Y, Ren Y, Wang J, Ye Z et al. • Antimicrobial agents and chemotherapy
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1128/aac.01026-26
PMC: PMC13731187
Torres L, Fishbaugher ME, Lam M, Chao AT et al. • Antimicrobial agents and chemotherapy
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1128/aac.01613-25
PMC: PMC13731184
Nussbaum JC, Pham MM, Vargo R, Liu Y et al. • Antimicrobial agents and chemotherapy
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1128/aac.00676-26
PMC: PMC13731176
Schärer A, Häberli C, Schlienger D, Keiser J • Antimicrobial agents and chemotherapy
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1128/aac.00825-26
PMC: PMC13731180
Duzgun D, Oltean S • Frontiers in bioinformatics
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.3389/fbinf.2026.1925354
PMC: PMC13731338
Liao W, Li Q, Deng Y, Zhang J et al. • Frontiers in oncology
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.3389/fonc.2026.1961360
PMC: PMC13735681
Huang X, Jiang S, Liu P • RSC advances
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1039/d6ra06159a
PMC: PMC13736793
Preti K, D'aoust R, Baker D, Pandey S et al. • Journal of the advanced practitioner in oncology
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.6004/jadpro.2026.17.7.24
PMC: PMC13738195
Wang Z, Yang K, Wang L, Zhao H et al. • Frontiers in pharmacology
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.3389/fphar.2026.1861637
PMC: PMC13541713
Li J, Han X, Zhuang Y, Liu Y et al. • Breast (Edinburgh, Scotland)
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1016/j.breast.2026.104906
PMC: PMC13545399
Pan C, Zhang R, Niu Y, Zhang W et al. • Translational cancer research
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.21037/tcr-2026-1-0328
PMC: PMC13559675
Yang Z, Dai Y, Li Y, Xia L et al. • BMC cancer
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1186/s12885-026-16403-6
PMC: PMC13628761
Somia IKA, Utama IMS, Gayatri AAAY, Sukmawati NMDD et al. • Infection & chemotherapy
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.3947/ic.2026.0006
PMC: PMC13655468
Jing Ma, Ruijuan Ma, Xueke Zeng, Liming Zhang et al. • Journal of Experimental & Clinical Cancer Research
(2023)
Abstract Background Platinum-drugs based chemotherapy in clinic increases the potency of tumor cells to produce M2 macrophages, thus leading to poor anti-metastatic activity and immunosuppression. Lysosome metabolism is critical for cancer ...
DOAJ
Open Access (DOAJ)
DOI: 10.1186/s13046-023-02768-0
Bin Zhao, Sa Chen, Ye Hong, Liangliang Jia et al. • Pharmaceutics
(2022)
The conventional cancer therapeutic modalities include surgery, chemotherapy and radiotherapy. Although immunotherapy and targeted therapy are also widely used in cancer treatment, chemotherapy remains the cornerstone of tumor treatment. Wi...
DOAJ
Open Access (DOAJ)
DOI: 10.3390/pharmaceutics14071522
Li Rong, Haiyu Li, Zhaodong Li, Jing Ouyang et al. • Frontiers in Medicine
(2020)
Background and Objective: Chemotherapy and radiotherapy are effective treatment options for cervical cancer (CC), but their efficacy is limited by short survival rate of about 5 years particularly for advance stage CC. Bioinformatics analys...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fmed.2020.608441